What is Pinometostat used for?

Pinometostat is being studied as a potential treatment for acute lymphoblastic leukemia and acute myeloid leukemia.

Is Pinometostat approved for use?

No, Pinometostat is currently in the clinical trial phase and has not received official approval.

What kind of drug is Pinometostat?

Pinometostat is classified as a small molecule drug.

What stage of testing is Pinometostat in?

Pinometostat is currently in Phase 2 of clinical development.

Can Pinometostat treat leukemia?

It is being researched for its ability to treat specific types of leukemia, such as acute myeloid leukemia.

What should I know about the safety of Pinometostat?

Since Pinometostat is still in clinical trials, its full safety profile and side effects are not yet fully established.

Pinometostat | CAS 1380288-88-9 | LXFOLMYKSYSZQS

Loading compound...

Small molecule research drug

Pinometostat is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential use in treating certain types of blood cancers, specifically acute lymphoblastic leukemia and acute myeloid leukemia.

How it worksPinometostat is a small molecule currently in the research phase (Phase 2) for treating leukemia.

Used for

acute lymphoblastic leukemiaacute myeloid leukemia

Conditions

acute lymphoblastic leukemiaacute myeloid leukemia

Class

small moleculeSmall molecule research drugblood

How to take

This drug is currently in clinical development and is not yet FDA-approved for general use.

Talk to your doctor

Questions to ask

·Is Pinometostat part of a clinical trial I can join?
·How does Pinometostat differ from my current leukemia treatment?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)